IBDEI0J9 ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,8949,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8949,1,3,0)
 ;;=3^Traumatic Glaucoma,Left Eye,Moderate Stage
 ;;^UTILITY(U,$J,358.3,8949,1,4,0)
 ;;=4^H40.32X2
 ;;^UTILITY(U,$J,358.3,8949,2)
 ;;=^5005858
 ;;^UTILITY(U,$J,358.3,8950,0)
 ;;=H40.32X3^^41^469^132
 ;;^UTILITY(U,$J,358.3,8950,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8950,1,3,0)
 ;;=3^Traumatic Glaucoma,Left Eye,Severe Stage
 ;;^UTILITY(U,$J,358.3,8950,1,4,0)
 ;;=4^H40.32X3
 ;;^UTILITY(U,$J,358.3,8950,2)
 ;;=^5133504
 ;;^UTILITY(U,$J,358.3,8951,0)
 ;;=H40.32X4^^41^469^129
 ;;^UTILITY(U,$J,358.3,8951,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8951,1,3,0)
 ;;=3^Traumatic Glaucoma,Left Eye,Indeterminate Stage
 ;;^UTILITY(U,$J,358.3,8951,1,4,0)
 ;;=4^H40.32X4
 ;;^UTILITY(U,$J,358.3,8951,2)
 ;;=^5005859
 ;;^UTILITY(U,$J,358.3,8952,0)
 ;;=H40.33X0^^41^469^128
 ;;^UTILITY(U,$J,358.3,8952,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8952,1,3,0)
 ;;=3^Traumatic Glaucoma,Bilateral,Unspec Stage
 ;;^UTILITY(U,$J,358.3,8952,1,4,0)
 ;;=4^H40.33X0
 ;;^UTILITY(U,$J,358.3,8952,2)
 ;;=^5005860
 ;;^UTILITY(U,$J,358.3,8953,0)
 ;;=H40.33X1^^41^469^125
 ;;^UTILITY(U,$J,358.3,8953,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8953,1,3,0)
 ;;=3^Traumatic Glaucoma,Bilateral,Mild Stage
 ;;^UTILITY(U,$J,358.3,8953,1,4,0)
 ;;=4^H40.33X1
 ;;^UTILITY(U,$J,358.3,8953,2)
 ;;=^5005861
 ;;^UTILITY(U,$J,358.3,8954,0)
 ;;=H40.33X2^^41^469^126
 ;;^UTILITY(U,$J,358.3,8954,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8954,1,3,0)
 ;;=3^Traumatic Glaucoma,Bilateral,Moderate Stage
 ;;^UTILITY(U,$J,358.3,8954,1,4,0)
 ;;=4^H40.33X2
 ;;^UTILITY(U,$J,358.3,8954,2)
 ;;=^5005862
 ;;^UTILITY(U,$J,358.3,8955,0)
 ;;=H40.33X3^^41^469^127
 ;;^UTILITY(U,$J,358.3,8955,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8955,1,3,0)
 ;;=3^Traumatic Glaucoma,Bilateral,Severe Stage
 ;;^UTILITY(U,$J,358.3,8955,1,4,0)
 ;;=4^H40.33X3
 ;;^UTILITY(U,$J,358.3,8955,2)
 ;;=^5005863
 ;;^UTILITY(U,$J,358.3,8956,0)
 ;;=H40.33X4^^41^469^124
 ;;^UTILITY(U,$J,358.3,8956,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8956,1,3,0)
 ;;=3^Traumatic Glaucoma,Bilateral,Indeterminate Stage
 ;;^UTILITY(U,$J,358.3,8956,1,4,0)
 ;;=4^H40.33X4
 ;;^UTILITY(U,$J,358.3,8956,2)
 ;;=^5005864
 ;;^UTILITY(U,$J,358.3,8957,0)
 ;;=H21.233^^41^469^26
 ;;^UTILITY(U,$J,358.3,8957,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8957,1,3,0)
 ;;=3^Degeneration of Iris,Bilateral
 ;;^UTILITY(U,$J,358.3,8957,1,4,0)
 ;;=4^H21.233
 ;;^UTILITY(U,$J,358.3,8957,2)
 ;;=^5005189
 ;;^UTILITY(U,$J,358.3,8958,0)
 ;;=H40.61X1^^41^469^40
 ;;^UTILITY(U,$J,358.3,8958,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8958,1,3,0)
 ;;=3^Drug-Induced Glaucoma,Right Eye,Mild Stage
 ;;^UTILITY(U,$J,358.3,8958,1,4,0)
 ;;=4^H40.61X1
 ;;^UTILITY(U,$J,358.3,8958,2)
 ;;=^5005907
 ;;^UTILITY(U,$J,358.3,8959,0)
 ;;=H40.013^^41^469^59
 ;;^UTILITY(U,$J,358.3,8959,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8959,1,3,0)
 ;;=3^Glaucoma Suspect/Open Angle w/ Borderline Findings,Low Risk,Bilateral
 ;;^UTILITY(U,$J,358.3,8959,1,4,0)
 ;;=4^H40.013
 ;;^UTILITY(U,$J,358.3,8959,2)
 ;;=^5005726
 ;;^UTILITY(U,$J,358.3,8960,0)
 ;;=H40.012^^41^469^60
 ;;^UTILITY(U,$J,358.3,8960,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8960,1,3,0)
 ;;=3^Glaucoma Suspect/Open Angle w/ Borderline Findings,Low Risk,Left Eye
 ;;^UTILITY(U,$J,358.3,8960,1,4,0)
 ;;=4^H40.012
 ;;^UTILITY(U,$J,358.3,8960,2)
 ;;=^5005725
 ;;^UTILITY(U,$J,358.3,8961,0)
 ;;=H40.011^^41^469^61
 ;;^UTILITY(U,$J,358.3,8961,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8961,1,3,0)
 ;;=3^Glaucoma Suspect/Open Angle w/ Borderline Findings,Low Risk,Right Eye
